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  3                        TC1 - Current Controversy in Management: Interactive Case Discussion   TC1
  3                        TC2 - How do I choose the correct disease-modifying treatment?         TC2.1 -- TC2.3
  4                        TC3 - Symptom management                                               TC3.1 -- TC3.3
  4                        TC4 - Management during pregnancy                                      TC4
  5                        TC5 - Clinically isolated syndromes (CIS)                              TC5.1 -- TC5.3
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  52                       PS9 - Treatment strategies in clinical practice                        PS9.3 -- PS9.6
  55                       PS10 - Immune mechanisms                                               PS10.1 -- PS10.6
  58                       PS11 - Gray matter pathology and mechanisms of progression             PS11.1 -- PS11.6
  60                       PS12 - Study design and endpoints                                      PS12.1 -- PS12.6
  63                       HT4 - Remyelination                                                    HT4.1 -- HT4.3
  64                       HT5 - Inflammation and neurodegeneration                               HT5.1 -- HT5.3
  65                       HT6 - Society and MS                                                   HT6.1 -- HT6.3
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